Amerika Serikat - Inggris - NLM (National Library of Medicine)

bryant ranch prepack - canagliflozin (unii: 0sac974z85) (canagliflozin anhydrous - unii:6s49dgr869), metformin hydrochloride (unii: 786z46389e) (metformin - unii:9100l32l2n) - invokamet and invokamet xr are a combination of canagliflozin and metformin hydrochloride (hcl) indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. canagliflozin is indicated to reduce the risk of major adverse cardiovascular events (cardiovascular death, nonfatal myocardial infarction and nonfatal stroke) in adults with type 2 diabetes mellitus and established cardiovascular disease (cvd). canagliflozin is indicated to reduce the risk of end-stage kidney disease (eskd), doubling of serum creatinine, cardiovascular (cv) death, and hospitalization for heart failure in adults with type 2 diabetes mellitus and diabetic nephropathy with albuminuria greater than 300 mg/day. limitations of use invokamet/invokamet xr is not recommended in patients with type 1 diabetes mellitus. it may increase the risk of diabetic ketoacidosis in these patients [see warnings and precautions (5.3)] . invokamet/invokamet xr is

Uni Eropa - Inggris - EMA (European Medicines Agency)

janssen-cilag international nv - canagliflozin - diabetes mellitus, type 2 - drugs used in diabetes - invokana is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise:as monotherapy when metformin is considered inappropriate due to intolerance or contraindicationsin addition to other medicinal products for the treatment of diabetes.for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4.4, 4.5 and 5.1.

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - canagliflozin hemihydrate 102mg equivalent to canagliflozin 100 mg - film coated tablet - 100 mg - active: canagliflozin hemihydrate 102mg equivalent to canagliflozin 100 mg excipient: croscarmellose sodium hyprolose lactose magnesium stearate microcrystalline cellulose opadry ii yellow 85f92209 - invokana is indicated in adults with type 2 diabetes mellitus, as an adjunct to diet and exercise, to improve glycaemic control as: monotherapy: when diet and exercise alone do not provide adequate glycaemic control in patients for whom the use of metformin is considered inappropriate due to intolerance or contraindications. add-on combination therapy: combination therapy with other anti-hyperglycaemic agents including insulin, when these, together with diet and exercise, do not provide adequate glycaemic control.

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - canagliflozin hemihydrate 306mg equivalent to canagliflozin 300 mg - film coated tablet - 300 mg - active: canagliflozin hemihydrate 306mg equivalent to canagliflozin 300 mg excipient: croscarmellose sodium hyprolose lactose magnesium stearate microcrystalline cellulose opadry white 85f18422 - invokana is indicated in adults with type 2 diabetes mellitus, as an adjunct to diet and exercise, to improve glycaemic control as: monotherapy: when diet and exercise alone do not provide adequate glycaemic control in patients for whom the use of metformin is considered inappropriate due to intolerance or contraindications. add-on combination therapy: combination therapy with other anti-hyperglycaemic agents including insulin, when these, together with diet and exercise, do not provide adequate glycaemic control.

Kenya - Inggris - Pharmacy and Poisons Board

canagliflozin / metformin - film-coated tablet - vokanamet 150mg/1000mg (canagliflozin/metformin) - metformin and canagliflozin

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - canagliflozin hemihydrate -

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - canagliflozin hemihydrate -

Kanada - Inggris - Health Canada

janssen inc - canagliflozin - tablet - 100mg - canagliflozin 100mg - sodium-glucose cotransporter 2 (sglt2) inhibitors

Kanada - Inggris - Health Canada

janssen inc - canagliflozin - tablet - 300mg - canagliflozin 300mg - sodium-glucose cotransporter 2 (sglt2) inhibitors

Kanada - Inggris - Health Canada

janssen inc - canagliflozin; metformin hydrochloride - tablet - 50mg; 500mg - canagliflozin 50mg; metformin hydrochloride 500mg - biguanides